Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients
暂无分享,去创建一个
C. Flask | R. Gubitosi-Klug | T. Sferra | S. Donnola | Maryanne O’Riordan | K. McBennett | K. Kutney | B. Kaminski
暂无分享,去创建一个
C. Flask | R. Gubitosi-Klug | T. Sferra | S. Donnola | Maryanne O’Riordan | K. McBennett | K. Kutney | B. Kaminski